Personnalisez votre veille

Inscrivez-vous gratuitement.

Espace publicitaire · 728×90

Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs

STAT | Reporting from the frontiers of health and medicine • Publié le 11 août 2026

Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.

Espace publicitaire · 300×250

WHO says Trump’s latest vaccine policy order is misguided

The White House's order attempting to overhaul the vaccine schedule could subject children to more needles and more disease risk, world health leaders say.

style youtuber•

🇬🇧 → 🇫🇷

STAT+: Cancer patients face longer wait times to begin treatment, according to new study

“Across every cancer we studied, patients are waiting longer today than they were a decade ago.”

style youtuber•

🇬🇧 → 🇫🇷

Opinion: The Lindsay Clancy case shows the limits of postpartum psychiatry

“Our understanding and treatment of postpartum psychiatric illnesses remain profoundly inadequate,” experts write.

style youtuber•

🇬🇧 → 🇫🇷

STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more

Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide

style youtuber•

🇬🇧 → 🇫🇷

STAT+: The secret AI-startup project I’ve been working on the last six months

In this edition of STAT's AI Prognosis: The messy reality of hastily developing and selling AI tools to clinics, and other health AI news.

style youtuber•

🇬🇧 → 🇫🇷

STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial

Definium Therapeutics said that its LSD therapy significantly helped patients with generalized anxiety disorder in the first of two large trials.

style youtuber•

🇬🇧 → 🇫🇷

STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies

German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment. Now he's co-founding his own company.

style youtuber•

🇬🇧 → 🇫🇷

STAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health care

Commure wants to automate health care's administrative tasks with AI. An inside look at the messy realities of the startup's ambitious quest.

style youtuber•

Personnalisez votre veille

Articles similaires

WHO says Trump’s latest vaccine policy order is misguided

STAT+: Cancer patients face longer wait times to begin treatment, according to new study

Opinion: The Lindsay Clancy case shows the limits of postpartum psychiatry

STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more

STAT+: The secret AI-startup project I’ve been working on the last six months

STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial

STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies

STAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health care